{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:41:36Z","timestamp":1776235296864,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:p>We present a case of successful rescue of primary graft failure following autologous hematopoietic stem cell transplantation (autoHSCT) in mantle cell lymphoma using a combination of darbepoetin, eltrombopag, and cyclosporine. Primary graft failure is a rare but serious complication of HSCT that may lead to life-threatening infections, bleeding, and increased overall morbidity and mortality. The underlying mechanisms of graft failure in autoHSCT are not well elucidated, and management options are often limited to autologous stem cell boost or allogeneic stem cell transplantation. Our case highlights the use of a combination of darbepoetin, eltrombopag, and cyclosporine as a potential novel multipronged strategy for rescuing primary graft failure following autoHSCT.<\/jats:p>","DOI":"10.3389\/frtra.2026.1811694","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:41:25Z","timestamp":1776231685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: A rare case of primary graft failure after autologous stem cell transplant for mantle cell lymphoma rescued with darbepoetin, eltrombopag, and cyclosporine"],"prefix":"10.3389","volume":"5","author":[{"given":"Seav Huong","family":"Ly","sequence":"first","affiliation":[{"name":"Department of Haematology, Singapore General Hospital","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan Chung Cheng","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Haematology, Singapore General Hospital","place":["Singapore, Singapore"]},{"name":"Division of Nursing, Singapore General Hospital","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeow Kheong","family":"Woon","sequence":"additional","affiliation":[{"name":"Department of Haematology, Singapore General Hospital","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandramouli","family":"Nargarajan","sequence":"additional","affiliation":[{"name":"Department of Haematology, Singapore General Hospital","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey Kim Siang","family":"Quek","sequence":"additional","affiliation":[{"name":"Department of Haematology, Singapore General Hospital","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeh Ching","family":"Linn","sequence":"additional","affiliation":[{"name":"Department of Haematology, Singapore General Hospital","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tertius T.","family":"Tuy","sequence":"additional","affiliation":[{"name":"Department of Haematology, Singapore General Hospital","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ajh.25487","article-title":"Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management","volume":"94","author":"Jain","year":"2019","journal-title":"Am J Hematol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41409-025-02599-x","article-title":"How we treat mantle cell lymphoma with cellular therapy in 2025: the European and American perspectives","volume":"60","author":"Dreger","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","article-title":"Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the American Society for Transplantation and Cellular Therapy","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"B5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-3-031-44080-9_41","article-title":"Graft failure","volume-title":"The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies","author":"Valc\u00e1rcel","year":"2024"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41409-022-01659-w","article-title":"Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and al amyloidosis","volume":"57","author":"Cook","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/146532402317381839","article-title":"The storage and re-infusion of autologous blood and BM as back-up following failed primary hematopoietic stem-cell transplantation: a survey of European practice","volume":"4","author":"Pottinger","year":"2002","journal-title":"Cytotherapy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3109\/10428194.2014.930849","article-title":"Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients","volume":"56","author":"Ferr\u00e0","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.bbmt.2008.05.005","article-title":"Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation: results of a single institution analysis","volume":"14","author":"Rond\u00f3n","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.bbmt.2020.03.009","article-title":"Risk factors, clinical outcomes, and cost-of-care related to graft failure in pediatric allogeneic hematopoietic cell transplant recipients","volume":"26","author":"Wobma","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4274\/balkanmedj.galenos.2022.2022-2-48","article-title":"Eltrombopag for the treatment of poor graft function following haematopoietic cell transplantation: real-life data","volume":"40","author":"K\u0131rcal\u0131","year":"2023","journal-title":"Balkan Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/01.HS9.0000848176.34514.00","article-title":"P1328: Succesful treatment of graft failure in autologous stem cell transplantation with cyclosporine","volume":"6","author":"Cubillas","year":"2022","journal-title":"HemaSphere"},{"key":"B14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbmt.2004.10.003","article-title":"Re: Failure to engraft after autologous stem cell transplantation: possible therapeutic role of cyclosporine","volume":"11","author":"Kamble","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.31547\/bct-2025-006","article-title":"Response to cyclosporine & eltrombopag in primary graft failure after autologous transplant in myeloma","volume":"8","author":"Shrinidhi","year":"2025","journal-title":"Blood Cell Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","article-title":"Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo\u2013purged stem cell rescue: a nonrandomized phase 2 multicenter study by the nordic lymphoma group","volume":"112","author":"Geisler","year":"2008","journal-title":"Blood J Am Soc Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bbmt.2016.12.634","article-title":"Molecular monitoring after autologous stem cell transplantation and preemptive rituximab treatment of molecular relapse; results from the nordic mantle cell lymphoma studies (MCL2 and MCL3) with median follow-up of 8.5 years","volume":"23","author":"Kolstad","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.transci.2006.08.009","article-title":"Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT)","volume":"36","author":"Ergene","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-018-0649-6","article-title":"Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag","volume":"11","author":"Tang","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault de Latour","year":"2022","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00062752-200005000-00010","article-title":"Role of thrombopoietin in hematopoietic stem cell and progenitor regulation","volume":"7","author":"Drachman","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.scr.2012.05.001","article-title":"Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem\/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis","volume":"9","author":"Sun","year":"2012","journal-title":"Stem Cell Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2018-11-884486","article-title":"Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-\u03b3","volume":"133","author":"Alvarado","year":"2019","journal-title":"Blood J Am Soc Hematol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"eaas9563","DOI":"10.1126\/scitranslmed.aas9563","article-title":"Thrombopoietin receptor\u2013independent stimulation of hematopoietic stem cells by eltrombopag","volume":"10","author":"Kao","year":"2018","journal-title":"Sci Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.bbrc.2018.03.012","article-title":"Cyclosporin a inhibits adipogenic differentiation and regulates immunomodulatory functions of murine mesenchymal stem cells","volume":"498","author":"Qu","year":"2018","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1811694\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:41:30Z","timestamp":1776231690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1811694\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":25,"alternative-id":["10.3389\/frtra.2026.1811694"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2026.1811694","relation":{},"ISSN":["2813-2440"],"issn-type":[{"value":"2813-2440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1811694"}}